Search

Author/Creator Konopleva, M.

11. P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB. (23rd June 2022)

Authors:
Macaron, W.; Jabbour, E.; Konopleva, M.; Ravandi, F.; Jain, N.; Issa, G.; Kadia, T.; Sasaki, K.; Kebriaei, P.; Yilmaz, M.; Thompson, P.; Takahashi, K.; Abbas, H.; Wierda, W.; Garris, R.; Kantarjian, H.; Short, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS UNFIT FOR CHEMOTHERAPY. (23rd June 2022)

Authors:
Abuasab, T.; Alvarado, Y.; Issa, G.; Islam, R.; Short, N.; Yilmaz, M.; jain, N.; Masarova, L.; Kornblau, S.; Jabbour, E.; Pemmaraju, N.; Montalban-Bravo, G.; Pierce, S.; DiNardo, C.; Kadia, T.; Daver, N.; Konopleva, M.; Garcia-Manero, G.; Ravandi, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
394
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. P506: ACHIEVEMENT OF MEASURABLE RESIDUAL DISEASE CLEARANCE IS A STRONGER PREDICTOR OF PATIENT OUTCOME THAN TREATMENT INTENSITY IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA. (23rd June 2022)

Authors:
Bazinet, A.; Kadia, T.; Short, N.; Borthakur, G.; Wang, S.; Loghavi, S.; Jorgensen, J.; Patel, K.; DiNardo, C.; Daver, N.; Alvarado, Y.; Haddad, F.; Pierce, S.; Andreeff, M.; Jabbour, E.; Konopleva, M.; Kantarjian, H.; Ravandi, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
405
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. P566: IMPACT OF FRONTLINE INDUCTION APPROACH ON POST-STEM CELL TRANSPLANT (SCT) OUTCOMES IN OLDER ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML). (23rd June 2022)

Authors:
Ong, F.; Ravandi, F.; Popat, U.; Kadia, T. M.; Daver, N.; DiNardo, C.; Konopleva, M.; Borthakur, G.; Shpall, E. J.; Oran, B.; Al-Atrash, G.; Mehta, R.; Jabbour, E. J.; Yilmaz, M.; Issa, G. C.; Garcia-Manero, G.; Maiti, A.; Abbas, H. A.; Champlin, R. E.; Short, N. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN COMBINATION WITH QUIZARTINIB FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH FLT3 OR CBL MUTATION. (23rd June 2022)

Authors:
Abuasab, T.; Jabbour, E.; Short, N.; Konopleva, M.; Chien, K. S.; Fareed Mohamed, S.; Daver, N.; Kanagal-shamanna, R.; Garcia-Manero, G.; Montalban-Bravo, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA. (23rd June 2022)

Authors:
Bazinet, A.; Jabbour, E.; Kantarjian, H.; Chien, K.; DiNardo, C.; Ohanian, M.; Daver, N.; Kanagal-Shamanna, R.; Kadia, T.; Takahashi, K.; Masarova, L.; Short, N.; Alvarado, Y.; Thompson, P.; Montalban-Bravo, G.; Yilmaz, M.; Ravandi, F.; Konopleva, M.; Andreeff, M.; Kornblau, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
652
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML. (23rd June 2022)

Authors:
Daver, N.; Maris, M.; Ramchandren, R.; Bixby, D.; Doucette, K.; Mawad, R.; Egan, D.; Stevens, D.; Zonder, J.; Molloy, N.; Scheuber, A.; Bruns, I.; Mantzaris, I.; Konopleva, M.; Goldberg, A. D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1700
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN. (23rd June 2022)

Authors:
Pemmaraju, N.; Martinelli, G.; Todisco, E.; Tarella, C.; Montesinos, P.; Lane, A. A.; Erba, H. P.; Sweet, K. L.; Walter, R. B.; Deconinck, E.; Wang, E. S.; Aribi, A.; Ulrikson, M. L.; Levy, M. Y.; Lebon, D.; Marconi, G.; DeAngelo, D. J.; Rizzieri, D.; Konopleva, M.; Sloss, C. M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1708
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Persistence of Preleukemic Clonal Hematopoiesis after Chemotherapy is Associated with Poor Prognosis in Patients with High Risk MDS and AML. (April 2017)

Authors:
Takahashi, K.; Wang, F.; Patel, K.; Bueso-Ramos, C.; Issa, G.; Song, X.; Zhang, J.; Little, L.; Gumbs, C.; Ravandi, F.; Kadia, T.; Daver, N.; Konopleva, M.; Andreeff, M.; Cortes, J.; Garcia-Manero, G.; Jabbour, E.; Futreal, A.; Kantarjian, H.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search